Zimmer Biomet Holdings Stock Performance
| ZBH Stock | USD 98.75 0.50 0.50% |
Zimmer Biomet has a performance score of 5 on a scale of 0 to 100. The firm maintains a market beta of 0.83, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Zimmer Biomet's returns are expected to increase less than the market. However, during the bear market, the loss of holding Zimmer Biomet is expected to be smaller as well. Zimmer Biomet Holdings right now maintains a risk of 1.47%. Please check out Zimmer Biomet Holdings skewness, and the relationship between the value at risk and day median price , to decide if Zimmer Biomet Holdings will be following its historical returns.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Zimmer Biomet Holdings are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak fundamental drivers, Zimmer Biomet may actually be approaching a critical reversion point that can send shares even higher in March 2026. ...more
Actual Historical Performance (%)
One Day Return (0.50) | Five Day Return 2.3 | Year To Date Return 9.7 | Ten Year Return 6.99 | All Time Return 242.05 |
Forward Dividend Yield 0.0097 | Payout Ratio | Last Split Factor 103:100 | Forward Dividend Rate 0.96 | Dividend Date 2026-01-30 |
1 | Disposition of tradable shares by Lori Winkler of Zimmer Biomet subject to Rule 16b-3 | 11/28/2025 |
2 | Acquisition by Michael Farrell of 415 shares of Zimmer Biomet at 90.33 subject to Rule 16b-3 | 12/31/2025 |
3 | Thoracic Outlet Syndrome Market Outlook 20252032 Strong CAGR of 5.9 percent with USD 351.17 Million Valuation Coherent Market Insights | 01/15/2026 |
4 | What Analysts Think Is Reframing Zimmer Biomet Story For Investors | 01/27/2026 |
5 | Acquisition by Kurdikar Devdatt of 1404 shares of Zimmer Biomet subject to Rule 16b-3 | 01/29/2026 |
| Zimmer Biomet dividend paid on 30th of January 2026 | 01/30/2026 |
6 | Zimmer Biomet Q4 2025 Earnings Preview | 02/09/2026 |
7 | Zimmer Biomet Holdings Healthcare Scope Within SP Futures Narratives | 02/10/2026 |
8 | ZBH Q4 Deep Dive U.S. Salesforce Overhaul Drives Guidance Caution Amid Product Momentum | 02/11/2026 |
9 | Zimmer Biomet Holdings Inc Q4 2025 Earnings Call Highlights Strong Revenue Growth and ... | 02/12/2026 |
10 | Zimmer Biomet Reshapes U.S. Sales Model As ROSA Knee Gains Ground | 02/13/2026 |
11 | The Top 5 Analyst Questions From Zimmer Biomets Q4 Earnings Call | 02/17/2026 |
12 | Acquisition by Shapiro Louis of 152 shares of Zimmer Biomet at 90.33 subject to Rule 16b-3 | 02/19/2026 |
| Begin Period Cash Flow | 525.5 M | |
| Total Cashflows From Investing Activities | -2 B |
Zimmer Biomet Relative Risk vs. Return Landscape
If you would invest 9,327 in Zimmer Biomet Holdings on November 23, 2025 and sell it today you would earn a total of 548.00 from holding Zimmer Biomet Holdings or generate 5.88% return on investment over 90 days. Zimmer Biomet Holdings is generating 0.1057% of daily returns assuming volatility of 1.4666% on return distribution over 90 days investment horizon. In other words, 13% of stocks are less volatile than Zimmer, and above 98% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Zimmer Biomet Target Price Odds to finish over Current Price
The tendency of Zimmer Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 98.75 | 90 days | 98.75 | about 1.46 |
Based on a normal probability distribution, the odds of Zimmer Biomet to move above the current price in 90 days from now is about 1.46 (This Zimmer Biomet Holdings probability density function shows the probability of Zimmer Stock to fall within a particular range of prices over 90 days) .
Zimmer Biomet Price Density |
| Price |
Predictive Modules for Zimmer Biomet
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Zimmer Biomet Holdings. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Zimmer Biomet Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Zimmer Biomet is not an exception. The market had few large corrections towards the Zimmer Biomet's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Zimmer Biomet Holdings, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Zimmer Biomet within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.09 | |
β | Beta against Dow Jones | 0.83 | |
σ | Overall volatility | 3.48 | |
Ir | Information ratio | 0.05 |
Zimmer Biomet Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Zimmer Biomet for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Zimmer Biomet Holdings can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Zimmer Biomet has a strong financial position based on the latest SEC filings | |
| Over 100.0% of the company outstanding shares are owned by institutional investors | |
| On 30th of January 2026 Zimmer Biomet paid $ 0.24 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: Acquisition by Shapiro Louis of 152 shares of Zimmer Biomet at 90.33 subject to Rule 16b-3 |
Zimmer Biomet Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Zimmer Stock often depends not only on the future outlook of the current and potential Zimmer Biomet's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Zimmer Biomet's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 198.7 M | |
| Cash And Short Term Investments | 591.9 M |
Zimmer Biomet Fundamentals Growth
Zimmer Stock prices reflect investors' perceptions of the future prospects and financial health of Zimmer Biomet, and Zimmer Biomet fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Zimmer Stock performance.
| Return On Equity | 0.056 | ||||
| Return On Asset | 0.0441 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.20 % | ||||
| Current Valuation | 26.04 B | ||||
| Shares Outstanding | 198.18 M | ||||
| Price To Earning | 77.41 X | ||||
| Price To Book | 1.50 X | ||||
| Price To Sales | 2.38 X | ||||
| Revenue | 8.23 B | ||||
| Gross Profit | 5.94 B | ||||
| EBITDA | 2.22 B | ||||
| Net Income | 705.2 M | ||||
| Cash And Equivalents | 591.9 M | ||||
| Cash Per Share | 2.71 X | ||||
| Total Debt | 7.52 B | ||||
| Debt To Equity | 0.48 % | ||||
| Current Ratio | 1.98 X | ||||
| Book Value Per Share | 64.43 X | ||||
| Cash Flow From Operations | 1.7 B | ||||
| Earnings Per Share | 3.55 X | ||||
| Market Capitalization | 19.57 B | ||||
| Total Asset | 23.09 B | ||||
| Retained Earnings | 11.1 B | ||||
| Working Capital | 2.22 B | ||||
| Current Asset | 5.85 B | ||||
| Current Liabilities | 1.62 B | ||||
About Zimmer Biomet Performance
By evaluating Zimmer Biomet's fundamental ratios, stakeholders can gain valuable insights into Zimmer Biomet's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Zimmer Biomet has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Zimmer Biomet has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 264.13 | 263.39 | |
| Return On Tangible Assets | 0.08 | 0.17 | |
| Return On Capital Employed | 0.07 | 0.06 | |
| Return On Assets | 0.03 | 0.03 | |
| Return On Equity | 0.06 | 0.05 |
Things to note about Zimmer Biomet Holdings performance evaluation
Checking the ongoing alerts about Zimmer Biomet for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Zimmer Biomet Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Zimmer Biomet has a strong financial position based on the latest SEC filings | |
| Over 100.0% of the company outstanding shares are owned by institutional investors | |
| On 30th of January 2026 Zimmer Biomet paid $ 0.24 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: Acquisition by Shapiro Louis of 152 shares of Zimmer Biomet at 90.33 subject to Rule 16b-3 |
- Analyzing Zimmer Biomet's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Zimmer Biomet's stock is overvalued or undervalued compared to its peers.
- Examining Zimmer Biomet's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Zimmer Biomet's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Zimmer Biomet's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Zimmer Biomet's stock. These opinions can provide insight into Zimmer Biomet's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Zimmer Stock analysis
When running Zimmer Biomet's price analysis, check to measure Zimmer Biomet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zimmer Biomet is operating at the current time. Most of Zimmer Biomet's value examination focuses on studying past and present price action to predict the probability of Zimmer Biomet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zimmer Biomet's price. Additionally, you may evaluate how the addition of Zimmer Biomet to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |